ChemicalBook > Product Catalog >Organic Chemistry >Carboxylic acids and derivatives >Carboxylic acid esters and derivatives >tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate

tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate

tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Suppliers list
Company Name: Cool Pharm, Ltd  
Tel: 021-60455363 18019463053
Email: sales@coolpharm.com
Company Name: JW & Y Pharmlab Co., Ltd.  
Tel: 021-64340559
Email: xinyu_shi@jwypharmlab.com.cn
Company Name: ShangHai Angti Biotechnology Co., Ltd.  
Tel: 13764913901
Email: info@angtibio.com
Company Name: TaiChem Taizhou Limited  
Tel: 052386810091
Email: zcwy9518@yeah.net
Company Name: Shanghai Changyan Chem & Tech Co., Ltd.  
Tel: 021-20242659 18930833303
Email: sales@changyanchem.cn
tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Basic information
Product Name:tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
Synonyms:tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate;6-Hydroxymethyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester;2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-6-(hydroxymethyl)-, 1,1-dimethylethyl ester;tert-butyl 6-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;2-Boc-6-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline
CAS:622867-52-1
MF:C15H21NO3
MW:263.33
EINECS:
Product Categories:
Mol File:622867-52-1.mol
tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Structure
tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Chemical Properties
Boiling point 403.7±45.0 °C(Predicted)
density 1.153±0.06 g/cm3(Predicted)
storage temp. 2-8°C
pka14.44±0.10(Predicted)
AppearanceWhite to off-white Solid
Safety Information
MSDS Information
tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Usage And Synthesis
UsesN-Boc-6-hydroxymethyl-1,2,3,4-tetrahydroisoquinoline is an intermediate used to prepare phosphonate-substituted HIV protease inhibitors for treatment of AIDS and other viral infections. It is also used in the synthesis of immunosuppressant heterocyclic compdounds for treating or preventing diseases assocd. with EDG receptor mediated signal transduction.
Synthesis
2-(TERT-BUTOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-6-CARBOXYLIC ACID

170097-67-3

tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate

622867-52-1

General procedure for the synthesis of tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate from 2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid: In Example 16, tert-butyl 6-bromomethyl-3,4-dihydro-1H-isoquinoline-2- carboxylate (D-1 ), the intermediate 6-bromomethyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid, was prepared as follows: firstly, under nitrogen protection, the Borane-THF complex (99.17 mL, 99.17 mmol) was slowly added to a solution of 2-(tert-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid (12.50 g, 45.08 mmol) in anhydrous THF (125.0 mL) via a syringe, and the reaction lasted for 16 h at 25 °C. Subsequently, water (10.0 mL) was slowly added followed by 2.0 M Na2CO3 solution (15.0 mL). The mixture was stirred for 15 min and then diluted with EtOAc to separate the organic layer. The organic layer was washed with 1 M HCl, dried over MgSO4 and concentrated under reduced pressure to give an oil. The oily substance was purified by silica gel chromatography to give the intermediate D-1-1 (11.8 g, 99.3% yield) as a white solid. Next, D-1-1 (9.50 g, 36.1 mmol) and N,N-diisopropylethylamine (9.43 mL, 54.1 mmol) were dissolved in dichloromethane (200.0 mL), triphenylphosphine dibromide (23.79 g, 54.11 mmol) was added, and the reaction was stirred for 1 hr and concentrated under reduced pressure. The resulting residue was purified by silica gel chromatography to afford the target product D-1 (8.74 g, 74% yield) as a white solid.

References[1] Patent: US2016/24059, 2016, A1. Location in patent: Paragraph 0308-0309
[2] Patent: WO2012/122340, 2012, A1. Location in patent: Page/Page column 77
[3] Patent: US2014/73629, 2014, A1. Location in patent: Paragraph 0100; 0101
[4] Patent: WO2017/160632, 2017, A1. Location in patent: Page/Page column 78; 79
[5] Patent: WO2017/216726, 2017, A1. Location in patent: Page/Page column 643-644
tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate Preparation Products And Raw materials
Raw materials2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid-->2-tert-Butyl 6-methyl 3,4-dihydroisoquinoline-2,6(1H)-dicarboxylate-->Water-->Tetrahydrofuran-->Sodium carbonate-->Borane THF
Tag:tert-butyl 6-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate(622867-52-1) Related Product Information
2-tert-Butyl 6-methyl 3,4-dihydroisoquinoline-2,6(1H)-dicarboxylate 2-Boc-1,2,3,4-Tetrahydroisoquinoline-6-Carbaldehyde(WX622024) 2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid tert-butyl 7-(hydroxymethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate 6-Isoquinolinemethanol, 1,2,3,4-tetrahydro-2-methyl- (1,2,3,4-tetrahydroisoquinolin-6-yl)methanol hydrochloride*